COBAS AMPLLIPREP / COBAS TAQMAN CMV TEST CE-IVD 04902068190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2014-05-02 for COBAS AMPLLIPREP / COBAS TAQMAN CMV TEST CE-IVD 04902068190 manufactured by Roche Molecular Systems.

Event Text Entries

[4434440] A customer in (b)(6) filed a complaint alleging that an over-quantitated cmv titer of 121,000 iu/ml was generated for one patient sample using the cobas ampliprep / cobas taqman (cap/ctm) cmv test. Three separate patient samples from the same patient were tested. The initial sample, run on (b)(6) 2014, generated a cmv titer of 916 iu/ml. A second sample was run on (b)(6) 2014 and generated a titer of 121,000 iu/ml. When repeated the same day, the titer was 160 iu/ml. A third sample was run on (b)(6) 2014 and generated a titer of 1070 iu/ml. It was stated in the complaint that the patient was (b)(6) tested by elisa and nat but is (b)(6) (testing dates, test used and data not provided). This mdr is being submitted for the cmv result of 122,000 iu/ml.
Patient Sequence No: 1, Text Type: D, B5


[11846381] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. Associated us product 04902025190 p110037. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[34939906] Date of this report 19-jun-2014. Description of event - updated to indicate that an additional data point was provided for the patient. Relevant tests/laboratory data, including dates - updated to include additional data point for the patient. Date additional information was received by manufacturer (19-jun-2014). Follow up report additional information/correction/device evaluation. Device evaluated by manufacturer: yes. (b)(4). A customer in chile alleged discrepant results with the cobas ampliprep/cobas taqman (b)(6) test for samples taken from the same patient. Results for the different collections were: (b)(6). It was noted that the customer does not perform daily maintenance of their instrumentation as prescribed in the product's labeling. Testing of the retain kit in question met specifications, and no issues were identified during release of the kit. The samples for this patient were not available for return, so the cause for the over-quantitation could not be further investigated or identified. (b)(4)
Patient Sequence No: 1, Text Type: N, H10


[34939907] Within the initial mdr 2243471-2014-00013, it was indicated that 4 test results from 3 samples collected from the same patient generated differing results with the cobas ampliprep/cobas taqman (cap/ctm) (b)(6) test. Over the course of the investigation, it was determined that 5 test results were generated for this patient. The 5th test result (631 iu/ml) was generated on (b)(6) 2014 with the first sample collected from this patient. This mdr follow-up is being submitted to address the over-quantitated result (121,000 iu/ml) originally reported in the initial mdr.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2243471-2014-00013
MDR Report Key3787255
Report Source01,05
Date Received2014-05-02
Date of Report2014-06-19
Date of Event2014-05-01
Date Mfgr Received2014-06-19
Date Added to Maude2014-06-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLLIPREP / COBAS TAQMAN CMV TEST CE-IVD
Generic NameCYTOMEGALOVIRUS (CMV) DNA QUANTITATIVE ASSAY
Product CodePAB
Date Received2014-05-02
Catalog Number04902068190
Lot NumberS10963
Device Expiration Date2014-12-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2014-05-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.